248 related articles for article (PubMed ID: 16814766)
1. Multiple mechanisms of hypocholesterolemic action of pactimibe, a novel acyl-coenzyme A:cholesterol acyltransferase inhibitor.
Kitayama K; Koga T; Inaba T; Fujioka T
Eur J Pharmacol; 2006 Aug; 543(1-3):123-32. PubMed ID: 16814766
[TBL] [Abstract][Full Text] [Related]
2. Importance of acyl-coenzyme A:cholesterol acyltransferase 1/2 dual inhibition for anti-atherosclerotic potency of pactimibe.
Kitayama K; Tanimoto T; Koga T; Terasaka N; Fujioka T; Inaba T
Eur J Pharmacol; 2006 Jul; 540(1-3):121-30. PubMed ID: 16730694
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological profile of SMP-797, a novel acyl-coenzyme a: cholesterol acyltransferase inhibitor with inducible effect on the expression of low-density lipoprotein receptor.
Ioriya K; Kino K; Horisawa S; Nishimura T; Muraoka M; Noguchi T; Ohashi N
J Cardiovasc Pharmacol; 2006 Feb; 47(2):322-9. PubMed ID: 16495773
[TBL] [Abstract][Full Text] [Related]
4. Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461.
Salisbury BG; Davis HR; Burrier RE; Burnett DA; Bowkow G; Caplen MA; Clemmons AL; Compton DS; Hoos LM; McGregor DG
Atherosclerosis; 1995 May; 115(1):45-63. PubMed ID: 7669087
[TBL] [Abstract][Full Text] [Related]
5. TMP-153, a novel ACAT inhibitor, inhibits cholesterol absorption and lowers plasma cholesterol in rats and hamsters.
Sugiyama Y; Ishikawa E; Odaka H; Miki N; Tawada H; Ikeda H
Atherosclerosis; 1995 Feb; 113(1):71-8. PubMed ID: 7755657
[TBL] [Abstract][Full Text] [Related]
6. Divergent pharmacologic activities of PD 132301-2 and CL 277,082, urea inhibitors of acyl-CoA:cholesterol acyltransferase.
Krause BR; Black A; Bousley R; Essenburg A; Cornicelli J; Holmes A; Homan R; Kieft K; Sekerke C; Shaw-Hes MK
J Pharmacol Exp Ther; 1993 Nov; 267(2):734-43. PubMed ID: 8246149
[TBL] [Abstract][Full Text] [Related]
7. The effect of acyl CoA: cholesterol acyltransferase inhibition on the uptake, esterification and secretion of cholesterol by the hamster small intestine.
Burrier RE; Smith AA; McGregor DG; Hoos LM; Zilli DL; Davis HR
J Pharmacol Exp Ther; 1995 Jan; 272(1):156-63. PubMed ID: 7815329
[TBL] [Abstract][Full Text] [Related]
8. Novel non-systemic inhibitor of ileal apical Na+-dependent bile acid transporter reduces serum cholesterol levels in hamsters and monkeys.
Kitayama K; Nakai D; Kono K; van der Hoop AG; Kurata H; de Wit EC; Cohen LH; Inaba T; Kohama T
Eur J Pharmacol; 2006 Jun; 539(1-2):89-98. PubMed ID: 16687134
[TBL] [Abstract][Full Text] [Related]
9. Effects of Bay o 2752, a hypocholesterolemic agent, on intestinal taurocholate absorption and cholesterol esterification.
Harnett KM; Walsh CT; Zhang LH
J Pharmacol Exp Ther; 1989 Nov; 251(2):502-9. PubMed ID: 2810110
[TBL] [Abstract][Full Text] [Related]
10. Combination of fish oil and fish protein hydrolysate reduces the plasma cholesterol level with a concurrent increase in hepatic cholesterol level in high-fat-fed Wistar rats.
Wergedahl H; Gudbrandsen OA; Røst TH; Berge RK
Nutrition; 2009 Jan; 25(1):98-104. PubMed ID: 18752928
[TBL] [Abstract][Full Text] [Related]
11. Pactimibe stabilizes atherosclerotic plaque through macrophage acyl-CoA:cholesterol acyltransferase inhibition in WHHL rabbits.
Kitayama K; Koga T; Maeda N; Inaba T; Fujioka T
Eur J Pharmacol; 2006 Jun; 539(1-2):81-8. PubMed ID: 16690054
[TBL] [Abstract][Full Text] [Related]
12. Anticholesterolemic effect of 3,4-di(OH)-phenylpropionic amides in high-cholesterol fed rats.
Kim SJ; Bok SH; Lee S; Kim HJ; Lee MK; Park YB; Choi MS
Toxicol Appl Pharmacol; 2005 Oct; 208(1):29-36. PubMed ID: 16164959
[TBL] [Abstract][Full Text] [Related]
13. Hypocholesterolemic and antioxidant properties of 3-(4-hydroxyl)propanoic acid derivatives in high-cholesterol fed rats.
Lee MK; Park YB; Moon SS; Bok SH; Kim DJ; Ha TY; Jeong TS; Jeong KS; Choi MS
Chem Biol Interact; 2007 Oct; 170(1):9-19. PubMed ID: 17662703
[TBL] [Abstract][Full Text] [Related]
14. Hypocholesterolemic activity of some novel azetidin-2-ones in diet and diabetes induced hypercholesterolemia in rats.
Goel RK; Thind JS; Bal CS; Mahajan MP; Kulkarni SK
Pharmazie; 2005 May; 60(5):369-74. PubMed ID: 15918588
[TBL] [Abstract][Full Text] [Related]
15. TMP-153, a novel ACAT inhibitor, lowers plasma cholesterol through its hepatic action in golden hamsters.
Sugiyama Y; Odaka H; Itokawa S; Ishikawa E; Tomari Y; Ikeda H
Atherosclerosis; 1995 Nov; 118(1):145-53. PubMed ID: 8579624
[TBL] [Abstract][Full Text] [Related]
16. Pyripyropene A, an acyl-coenzyme A:cholesterol acyltransferase 2-selective inhibitor, attenuates hypercholesterolemia and atherosclerosis in murine models of hyperlipidemia.
Ohshiro T; Matsuda D; Sakai K; Degirolamo C; Yagyu H; Rudel LL; Omura S; Ishibashi S; Tomoda H
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1108-15. PubMed ID: 21393580
[TBL] [Abstract][Full Text] [Related]
17. The hypolipidemic effect of a new ACAT inhibitor, VULM 1457, in diabetic-hypercholesterolaemic rats.
Adameová A; Kuzelová M; Faberová V; Svec P
Pharmazie; 2005 Sep; 60(9):714-5. PubMed ID: 16222877
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol-lowering effect of platycodin D in hypercholesterolemic ICR mice.
Zhao HL; Cho KH; Ha YW; Jeong TS; Lee WS; Kim YS
Eur J Pharmacol; 2006 May; 537(1-3):166-73. PubMed ID: 16626693
[TBL] [Abstract][Full Text] [Related]
19. [Effect of stimulation and inhibition of macrophage functions on hypercholesterolemia in rats].
Kuznetsov PO; Safina AF; Shvarts IaSh; Tsyrendorzhiev DD; Zubakhin AA; Dushkin MI
Vopr Med Khim; 2002; 48(2):180-8. PubMed ID: 12189625
[TBL] [Abstract][Full Text] [Related]
20. Berberine decreases cholesterol levels in rats through multiple mechanisms, including inhibition of cholesterol absorption.
Wang Y; Yi X; Ghanam K; Zhang S; Zhao T; Zhu X
Metabolism; 2014 Sep; 63(9):1167-77. PubMed ID: 25002181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
